PROCEPT BioRobotics Corporation (PRCT) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $1.04B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $22.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $1.02B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-19.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $1.01B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $37.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $991.95M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $42.00K.
PROCEPT BioRobotics Corporation Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $0.00 | $1.04B | $22.00K | $-700.06M | $340.07M | (m) | 3 month · $14.73M |
| 2026-03-31 | $0.00 | $0.00 | $1.02B | $-19.00K | $-673.20M | $347.67M | (m) | 3 month · $13.27M |
| 2025-12-31 | $0.00 | $0.00 | $1.01B | $37.00K | $-641.56M | $365.87M | (m) | 12 month · $48.11M |
| 2025-09-30 | $0.00 | $0.00 | $991.95M | $42.00K | $-611.71M | $380.28M | (m) | 3 month · $14.63M |
| 2025-06-30 | $0.00 | $0.00 | $976.24M | $-144.00K | $-590.30M | $385.80M | (m) | 3 month · $12.21M |
| 2025-03-31 | $0.00 | $0.00 | $959.66M | $223.00K | $-570.72M | $389.16M | (m) | 3 month · $10.27M |
| 2024-12-31 | $0.00 | $0.00 | $948.09M | $114.00K | $-545.99M | $402.22M | 12 month · $11.28M | 12 month · $32.73M |
| 2024-09-30 | $0.00 | $0.00 | $768.37M | $-18.00K | $-527.13M | $241.22M | (m) | 3 month · $8.71M |
| 2024-06-30 | $0.00 | $0.00 | $757.93M | $-1.00K | $-506.15M | $251.78M | (m) | 3 month · $8.18M |
| 2024-03-31 | $0.00 | $0.00 | $744.46M | $113.00K | $-480.53M | $264.05M | (m) | 3 month · $6.64M |
| 2023-12-31 | $0.00 | $0.00 | $735.24M | $84.00K | $-454.57M | $280.75M | 12 month · $10.79M | 12 month · $21.69M |
| 2023-09-30 | $0.00 | $0.00 | $726.43M | $-6.00K | $-427.07M | $299.36M | 3 month · $10.79K | 3 month · $5.96M |
| 2023-06-30 | $0.00 | $0.00 | $558.35M | $-6.00K | $-402.44M | $155.90M | (m) | 3 month · $5.65M |
| 2023-03-31 | $0.00 | $0.00 | $550.27M | $15.00K | $-377.16M | $173.13M | (m) | 3 month · $4.14M |
| 2022-12-31 | $0.00 | $0.00 | $545.75M | $-6.00K | $-348.68M | $197.07M | (m) | 12 month · $10.67M |
| 2022-09-30 | $0.00 | $0.00 | $541.05M | $217.00K | $-320.50M | $220.76M | (m) | 3 month · $3.23M |
| 2022-06-30 | $0.00 | $0.00 | $537.05M | $32.00K | $-297.89M | $239.19M | (m) | 3 month · $2.68M |
| 2022-03-31 | $0.00 | $0.00 | $531.51M | $-53.00K | $-278.71M | $252.75M | (m) | 3 month · $1.55M |
| 2021-12-31 | $0.00 | $0.00 | $528.67M | $-54.00K | $-261.52M | $267.09M | (m) | 12 month · $3.80M |
| 2021-09-30 | $0.00 | $0.00 | $526.53M | $-41.00K | $-243.17M | $283.31M | (m) | 3 month · $925.00K |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | $-206.31M | (m) | 3 month · $725.00K |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $-193.86M | (m) | 3 month · $650.00K |
| 2020-12-31 | $0.00 | $0.00 | $18.79M | $-14.00K | $-201.67M | $-182.89M | (m) | 12 month · $2.17M |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $-168.43M | (m) | 3 month · $563.00K |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-166.54M | (m) | 3 month · $445.00K |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-155.38M | (m) | 3 month · $561.00K |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $-143.84M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |